Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers von PHAM, P. A, LA PORTE, C. J. L, CAMERON, D. W, LEE, L. S, VAN HEESWIJK, R, SABO, J. P, ELGADI, M. M, PILIERO, P. J, BARDITCH-CROVO, P, FUCHS, E, FLEXNER, C

Volltext

Pharmacokinetic Properties of Nucleoside/Nucleotide Reverse Transcriptase Inhibitors von Piliero, Peter J

Volltext

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials von Nelson, Mark, Arastéh, Keikawus, Clotet, Bonaventura, Cooper, David A, Henry, Keith, Katlama, Christine, Lalezari, Jacob P, Lazzarin, Adriano, Montaner, Julio S. G, OʼHearn, Mary, Piliero, Peter J, Reynes, Jacques, Trottier, Benoit, Walmsley, Sharon L, Cohen, Calvin, Eron, Joseph J, Kuritzkes, Daniel R, Lange, Joep, Stellbrink, Hans-Jürgen, Delfraissy, Jean-François, Buss, Neil E, Donatacci, Lucille, Wat, Cynthia, Smiley, Lynn, Wilkinson, Martin, Valentine, Adeline, Guimaraes, Denise, DeMasi, Ralph, Chung, Jain, Salgo, Miklos P

Volltext

Use of Ultrasonography-Assisted Liposuction for the Treatment of Human Immunodeficiency Virus—Associated Enlargement of the Dorsocervical Fat Pad von Piliero, P. J., Hubbard, M., King, J., Faragon, J. J.

Volltext

Atazanavir: a novel HIV-1 protease inhibitor von Piliero, Peter J

Volltext

Guillain-Barré Syndrome Associated with Immune Reconstitution von Piliero, Peter J., Fish, Douglas G., Preston, Sandra, Cunningham, Donna, Kinchelow, Tosca, Salgo, Miklos, Qian, Jiang, Drusano, George L.

Volltext

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy von CLIFFORD, D. B, YIANNOUTSOS, C, TSELIS, A. C, HYSLOP, N. E, GLICKSMAN, M, SIMPSON, D. M, SINGER, E. J, PILIERO, P. J, MARRA, C. M, FRANCIS, G. S, MCARTHUR, J. C, TYLER, K. L

Volltext

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy von Clifford, D B, Yiannoutsos, C, Glicksman, M, Simpson, D M, Singer, E J, Piliero, P J, Marra, C M, Francis, G S, McArthur, J C, Tyler, K L, Tselis, A C, Hyslop, N E

Volltext

Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers von SADLER, Brian M, PILIERO, Peter J, PRESTON, Sandra L, LLOYD, Peggy P, YU LOU, STEIN, Daniel S

Volltext

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America von Lalezari, Jacob P, Henry, Keith, O'Hearn, Mary, Montaner, Julio S.G, Piliero, Peter J, Trottier, Benôit, Walmsley, Sharon, Cohen, Calvin, Kuritzkes, Daniel R, Eron, Joseph J, Chung, Jain, DeMasi, Ralph, Donatacci, Lucille, Drobnes, Claude, Delehanty, John, Salgo, Miklos

Volltext

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults von Priddy, Frances H., Brown, Deborah, Kublin, James, Monahan, Kathleen, Wright, David P., Lalezari, Jacob, Santiago, Steven, Marmor, Michael, Lally, Michelle, Novak, Richard M., Brown, Stephen J., Kulkarni, Priya, Dubey, Sheri A., Kierstead, Lisa S., Casimiro, Danilo R., Mogg, Robin, DiNubile, Mark J., Shiver, John W., Leavitt, Randi Y., Robertson, Michael N., Mehrotra, Devan V., Quirk, Erin

Volltext

The utility of inhibitory quotients in determining the relative potency of protease inhibitors von PILIERO, Peter J

Volltext

Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and... von Sanne, Ian, Piliero, Peter, Squires, Kathleen, Thiry, Alexandra, Schnittman, Steven

Volltext

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection von Flynn, Neil M, Forthal, Donald N, Harro, Clayton D, Judson, Franklyn N, Mayer, Kenneth H, Para, Michael F

Volltext

Nevirapine-induced hepatitis: a case series and review of the literature von Piliero, P J, Purdy, B

Volltext

Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults von LALEZARI, Jacob, THOMPSON, Melanie, BERREY, Michelle, PISCITELLI, Stephen, KUMAR, Priny, PILIERO, Peter, DAVEY, Richard, PATTERSON, Kristine, SHACHOY-CLARK, Anne, ADKISON, Kimberly, DEMAREST, James, YU LOU

Volltext

Acute Uveitis Associated With Rifabutin Use in Patients With Human Immunodeficiency Virus Infection von Jacobs, Deborah S., Piliero, Peter J., Kuperwaser, Mark G., Smith, Jill A., Harris, Scott D., Flanigan, Timothy P., Goldberg, Joan H., Ives, David V.

Volltext

In Vitro-In Vivo Model for Evaluating the Antiviral Activity of Amprenavir in Combination with Ritonavir Administered at 600 and 100 Milligrams, Respectively, Every 12 Hours von PRESTON, Sandra L, PILIERO, Peter J, BILELLO, John A, STEIN, Daniel S, SYMONDS, William T, DRUSANO, George L

Volltext

Effect of Ritonavir-Boosted Tipranavir or Darunavir on the Steady-State Pharmacokinetics of Elvitegravir von Mathias, Anita A, Hinkle, John, Shen, Gong, Enejosa, Jeff, Piliero, Peter J, Sekar, Vanitha, Mack, Rebecca, Tomaka, Frank, Kearney, Brian P

Volltext

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial von HAAS, David W, ZALA, Carlos, SCHRADER, Shannon, PILIERO, Peter, JAEGER, Hans, NUNES, Danilo, THIRY, Alexandra, SCHNITTMAN, Steven, SENSION, Michael

Volltext